Hyper-Ex
Hyper-Ex, licence 80000292: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Thorne Research, Inc.
- NPN or DIN-HM
- 80000292
- Status
- Active licence
- Licence date
- 4 February 2005
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Traditionally used as a sedative for relief of restlessness or nervousness. Helps to treat symptoms of sleep disorders.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Avoid prolonged exposure to sunlight, ultraviolet light, or UV therapy. Consult a health care practitioner if you are taking any conventional medication, such as Contraceptives, HIV-1 protease inhibitors, non-nucleoside reverse transcriptase inhibitors, immunosuppressants, anticoagulant, digoxin, theophylline, serotonergic antidepressants, migraine therapies, SSRIs and/or anti-epilepsy drugs. If symptoms persist consult a health care practitioner.
- Contre-indications
Do not use if you are pregnanat or breastfeeding.
- Effets indésirables connus
Consult a health care provider if you experience sleep disturbances.
Source
Official Health Canada record, licence 80000292
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.